## DT2Vec: a computational approach to predict drug-target interactions using  machine learning
##### E. Amiri Souri<sup>1</sup>, R. Laddach<sup>1,2</sup>, S. N. Karagiannis<sup>2,3</sup>,L.G. Papageorgiou<sup>4</sup>,  S. Tsoka<sup>1</sup>

<sup> 1 Department of Informatics, Faculty of Natural and Mathematical Sciences, King's College London, Bush House, London WC2B 4BG, United Kingdom <br />
2 St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, & NIHR Biomedical Research Centre at Guy’s and St. Thomas’ Hospitals and King’s College London, Guy’s Hospital, King’s College London, London SE1 9RT, United Kingdom <br />
3 Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King’s College London, Guy’s Cancer Centre, London SE1 9RT, United Kingdom <br />
4 Centre for Process Systems Engineering, Department of Chemical Engineering, University College London, Roberts Building, Torrington Place, London WC1E 7JE, United Kingdom <br />
